Glycemic control in the ICU: a multicenter survey
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
Intensive insulin therapy has recently been shown to decrease morbidity and mortality in the critically ill population in a large randomized clinical trial.
To determine the beliefs and attitudes of ICU clinicians about glycemic control.
ICU nurses and physicians in five university-affiliated multidisciplinary ICUs.
A total of 317 questionnaires were returned from 233 ICU nurses and 84 physicians. The reported clinically important threshold for hypoglycemia was 4 mmol/l (median, IQR 3–4 mmol/l). In non-diabetic patients, the clinically important threshold for hyperglycemia was 10 mmol/l (IQR 9–12 mmol/l); however, nurses had a significantly higher threshold than physicians (difference of 0.52 mmol/l (95% CI 0.09–0.94 mmol/l, P=0.018). In diabetic patients, the clinically important threshold for hyperglycemia was also 10 mmol/l (IQR 10–12 mmol/l), and again nurses had a significantly higher threshold than physicians (0.81 mmol/l, 95% CI 0.29–1.32 mmol/l, P=0.0023). Avoidance of hyperglycemia was judged most important for diabetic patients (87.7%, 95% CI 84.1–91.3%), patients with acute brain injury (84.5%, 95% CI 80.5–88.5%), patients with a recent seizure (74.4%, 95% CI 69.6–79.3%), patients with advanced liver disease (64.0%, 95% CI 58.7–69.3%), and for patients with acute myocardial infarction (64.0%, 95% CI 58.7–69.3%). Physicians expressed more concern than nurses about avoiding hyperglycemia in patients with acute myocardial infarction (P=0.0004). ICU clinicians raised concerns about the accuracy of glucometer measurements in critically ill patients (46.1%, 95% CI 40.5–51.6%).
Attention to these beliefs and attitudes could enhance the success of future clinical, educational and research efforts to modify clinician behavior and achieve better glycemic control in the ICU setting.
- Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the long term complications in insulin dependent diabetes mellitus. N Engl J Med 329:977–986
- UK Prospective Diabetes Study Group (1998) Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853
- Capes SE, Hunt D, Malmberg K, Gerstein HC (2000) Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355:773–778
- Capes SE, Hunt D, Malberg K, Pathak P, Gerstein H (2001) Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32:2426–2432
- Malmberg K, Ryden L, Efendic S, Nicol P, Waldenström A, Wedel H, Welin L (1995) Randomized trial of insulin-glucose followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at one year. J Am Coll Cardiol 26:57–65
- Malmberg K (1997) Prospective randomized study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus (DIGAMI). BMJ 314:1512–1515
- Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359–1367
- Umpierrez GE, Isaccs SD, Bazargan N, You X, Thaler LM, Kitabchi AE (2002) Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 87:978–982
- Cook DJ, Guyatt GH, Juniper E, Griffith L, McIlroy W, Willan A, Jaeschke R, Epstein R (1993) Interviewer versus self-administered questionnaires in developing a disease-specific, health-related quality of life instrument for asthma. J Clin Epidemiol 46:529–534
- Balas EA, Weingarten S, Garb C, Blumenthal D, Boren SA, Brown GD (2000) Improving preventive care by prompting physicians. Arch Intern Med 160:301–308 CrossRef
- Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, Malmberg K (2002) Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359:2140–2144 CrossRef
- Brown G, Dodek P (2001) Intravenous insulin infusion nomogram improves blood glucose control in the critically ill. Crit Care Med 29:1714–1719
- Ray J, Hamielec C, Matracci T (2001) Pilot study of the accuracy of bedside glucometry in the intensive care unit. Crit Care Med 29:2205–2207 CrossRef
- Brozek J, McMullin J, Jaeschke R, Waugh L, Gibson J, Cook DJ (2003) Glycemic control in the ICU: comparing glucometer versus laboratory measurements. Am J Resp Crit Care Med 167:A252
- Griffith LE, Cook DJ, Guyatt GH, Charles C (1999) Comparison of open versus closed questionnaire formats in obtaining demographic information from Canadian general internists. J Clin Epidemiol 52:997–1005 CrossRef
- Edwards P, Roberts I, Clarke M, DiGuiseppi C, Pratap S, Wentz R (2002) Increasing response rates to postal questionnaires: systematic review. BMJ 324:1183–1191 CrossRef
- Grimshaw JM, Shirran L, Thomas R, Mowatt G, Fraser C, Bero L, Grilli R, Harvey E, Oxman A, O’Brien MA (2001) Changing provider behavior: an overview of systematic reviews of interventions. Med Care 39:2–45 CrossRef
- Glycemic control in the ICU: a multicenter survey
Intensive Care Medicine
Volume 30, Issue 5 , pp 798-803
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Critically ill
- Industry Sectors
- Author Affiliations
- 1. Department of Medicine, McMaster University, Hamilton, Canada
- 2. Jagiellonian University School of Medicine, Krakow, Poland
- 3. Program of Critical Care, University of British Columbia, Vancouver, Canada
- 4. Department of Medicine, Dalhousie University, Halifax, Canada
- 5. Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Canada
- 6. Departments of Medicine & Clinical Epidemiology, McMaster University Medical Center, 1200 Main St West, Hamilton, Ontario, Canada